Notice about cookies

Close

This website uses a limited number of cookies to improve your browsing experience. For further information (including how to withdraw consent), please refer to our Cookie Policy. By clicking Accept below or continuing to use this website (including closing this message), you confirm that you have read and consent to our use of cookies as detailed in our Cookie Policy.

Accept

UCB's Global Corporate Website
Welcome to UCB in the United States

Categories

Archives

Jun

27

Fulfilling Our Ambition to Deliver an FDA-Approved Treatment for People Living with Generalized Myasthenia Gravis

Read More Share:linkedin| twitter| email

Jun

27

UCB announces U.S. FDA approval of RYSTIGGO® (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis

Read More Share:linkedin| twitter| email

Jun

14

How UCB Is Supporting the Mental Health of Patients and Caregivers

Read More Share:linkedin| twitter| email

Jun

14

Recognizing Ethical Leadership at UCB

Read More Share:linkedin| twitter| email

Jun

08

Employee Spotlight: Natasha Trujillo’s Passion for Advocacy

Read More Share:linkedin| twitter| email

Jun

02

Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome

Read More Share:linkedin| twitter| email

Jun

01

Myasthenia Gravis Awareness Month is the Time to Understand More About the Lived Experiences of the Community

Read More Share:linkedin| twitter| email

© 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
USPR-CORP-0115-00003(2)